Regulated cannabis push in India: Himachal Pradesh approved regulated cannabis cultivation for industrial hemp and medical/scientific use, aiming to shift farmers from traditional crops and boost revenue (with “green to gold” plans tied to textiles, ayurvedic medicines and other products). Pain science without the “high”: University of Arizona researchers highlighted cannabis terpenes as potential pain relief for fibromyalgia and post-surgical pain, pointing to options that may avoid THC-style psychoactive effects. Policy debate on what legalization really changes: A global review in The Lancet says decriminalization or tightly controlled access doesn’t clearly raise overall use, but commercial for-profit markets are linked to higher addiction and more psychiatric hospital admissions. Cultivation tech spotlight: A Phoenix facility is using aeroponics (soil-free, mist-fed roots) and claims major water savings while speeding growth. Public safety + enforcement: Malaysia reported hundreds of vape cases tied to synthetic drugs, strengthening calls for a vape ban; separately, courts in the UK continued cannabis drug-driving enforcement with fines and bans. US legal market economics: A report says US states have generated $28.4B in recreational cannabis tax revenue since legalization began, with 2025 marking the biggest annual haul.